Light AI Announces Initiation Of FDA Pivotal Clinical Trial For QuickscanTM Strep A Software As A Medical Device (SaMD)

Ethics Committee Approval Received for Pivotal Study Intended to Support U.S. FDA Class II Submission for QuickScanTM Strep A VANCOUVER, BC, June 4,...